STILLWATER, Minn. – A collaboration with the Children’s Hospitals and Clinics of Minnesota is testing the mission behind Pops! Diabetes Care mobile diabetes management device.
The device adheres to the back of a smartphone and includes three stationary lancets next to three strips on a disposable module. The meter communicates via Bluetooth with a companion mobile app, which also allows caregivers and providers to remotely monitor the patient’s glucose readings and more.
“We’re all about creating a fabulous user experience,” said Lonny Stormo, CEO of Pops! Diabetes Care, a diabetes patient himself. “The majority of people with diabetes don’t want to use all of the new, complicated technology that’s out there for diabetes—including me.”
Children’s Hospitals was looking for an easy-to-use diabetes management system for its young patients and their families, as well as physicians and diabetes educators, and conducted a study around mHealth and diabetes last year. It found that what’s available in the mHealth app marketplace today is not meeting their needs.
Children’s Hospitals connected with Stormo at the 2015 MN Cup competition, in which Pops! was a runner-up, and began using the system last year.
“To collaborate on developing a product that potentially may simplify the 24/7 burden of diabetes management on pediatric patients is exciting,” said Dr. Laura Gandrud, a pediatric endocrinologist at Children’s McNeely Pediatric Diabetes Center, part of Children’s Hospitals, in a statement.
Remote monitoring has been the focus of the diabetes management space for many years, said Stormo, but data hasn’t always been accessible to the patient.
“People are willing to take their health care into their own hands and we’re trying to give them the right tools to do that,” Stormo said. “We’re hoping to see a change that enables people to be less dependent on a clinic or health professional to get better outcomes.”
Pops! will apply for U.S. Food and Drug Administration clearance later this year, and it’s planning to conduct a clinical trial with Children’s Hospitals, as well.